Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.

Medically reviewed by Kira Graves, PhD "Hangxiety" is a term used to describe a feeling of nervousness or unease after drinking alcohol. Usually, these symptoms of irritability or a sense of ...

H.C. Wainwright analyst Pat Trucchio adjusted the price target for Cybin Inc. (NYSE:CYBN) stock, lowering it to $150.00 from the previous $190.00 while maintaining a Buy rating on the company.

A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Engelman faults Health Ministry for 'collapsed' health care system; Health Minister Uriel Buso set to double the scope of ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

A new study suggests that people who visit the emergency department (ED) due to cannabis use may have a much higher risk of developing anxiety disorders. Within three years, 27% of these individuals ...

More than four hours before police arrived, Denise Lozano, a longtime employee of Vista-based natural soap maker Dr.

You're probably familiar with the symptoms of anxiety: feeling worried, racing thoughts, and being irritable. But while being ...

The business offers therapy services for individuals with various experiences including anxiety, OCD and depression.